首页> 外文OA文献 >Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea.

【2h】

Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea.

机译：韩国晚期非小细胞肺癌患者EGFR突变和一线靶向治疗伴随诊断检测的经济学评价。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Eun-A Lim; Haeyoung Lee; Eunmi Bae; Jaeok Lim; Young Kee Shin; Sang-Eun Choi;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors combined with chemotherapy in first-line treatment in an advanced non-small cell lung cancer patient with EGFR sensitive mutation [J] . Huang Aimi, Li Rong, Zhao Jikai, Thoracic cancer. . 2016,第5期

机译：表皮生长因子受体（EGFR）-酪氨酸激酶抑制剂联合化疗在一线治疗晚期EGFR敏感突变的非小细胞肺癌患者中的一线治疗
2. Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors combined with chemotherapy in first-line treatment in an advanced non-small cell lung cancer patient with EGFR sensitive mutation [J] . Jie Zhang, Hasan Ali Kiraz, Tuncer Simsek, Thoracic cancer. . 2016,第5期

机译：表皮生长因子受体（EGFR）-酪氨酸激酶抑制剂联合化疗在一线治疗晚期EGFR敏感突变的非小细胞肺癌患者中的一线治疗
3. Icotinib alone or with bevacizumab as first-line therapy in Chinese patients with advanced nonsquamous non-small cell lung cancer and activating EGFR mutations: A retrospective study [J] . Zhansheng Jiang, Jing Zhang, Haiyan Sun, Thoracic cancer. . 2021,第17期

机译：单独的icotinib或贝伐单抗作为中国晚期非小细胞肺癌患者的一线治疗和激活EGFR突变：回顾性研究
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Application of Quantitative Metrics for EGFR-Targeted Non-Small Cell Lung Cancer Therapy Using [11C]Erlotinib PET. [D] . Petrulli, Joseph Ryan. 2017

机译：定量指标在EGFR靶向非小细胞肺癌治疗中的应用[11C]厄洛替尼PET。
6. Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea [O] . Eun-A Lim, Haeyoung Lee, Eunmi Bae, 2011

机译：韩国晚期非小细胞肺癌患者EGFR突变和一线靶向治疗的同伴诊断测试的经济评估
7. Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea. [O] . Eun-A Lim, Haeyoung Lee, Eunmi Bae, 2016

机译：韩国晚期非小细胞肺癌患者EGFR突变和一线靶向治疗伴随诊断检测的经济学评价。

Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea.

著录项

引文网络

相似文献

相关主题

期刊订阅